| Symbol | TFX |
|---|---|
| Name | TELEFLEX INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 550 E SWEDESFORD RD, WAYNE, PA 19087 |
| Telephone | 610-225-6800 |
| Fax | — |
| — | |
| Website | https://www.teleflex.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000096943 |
| Description | Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. Additional info from NASDAQ: |
Teleflex - Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.
Read moreTeleflex Awarded National Central Venous Access Agreement with Premier, Inc.
Read moreTeleflex - Teleflex Initiates Enrollment in GlobalBIOMAG™‑III Pivotal Trial ofFreesolve™ Resorbable Magnesium Scaffold
Read moreTeleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
Read moreDirector RANDLE STUART A 🟡 adjusted position in 3.8K shares (1 derivative) of TELEFLEX INC (TFX) at $131.74 Transaction Date: Jun 07, 2026 | Filing ID: 000078
Read moreDirector Weidman Jason R. 🟢 acquired 80.1K shares (1 derivative) of TELEFLEX INC (TFX) at $131.74 ($3.4M) Transaction Date: Jun 08, 2026 | Filing ID: 000076
Read moreNew Form 3 - TELEFLEX INC <b>Filed:</b> 2026-06-09 <b>AccNo:</b> 0000096943-26-000074 <b>Size:</b> 443 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07258290 | Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold … | Na | Coronary Disease | Recruiting | 2026-06-11 | 2033-06-01 | ClinicalTrials.gov |
| NCT07292818 | Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies | Phase1 | Cervix Cancer | Recruiting | 2026-02-02 | 2030-10-30 | ClinicalTrials.gov |
| NCT06779630 | Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary… | Na | Coronary Artery Disease | Recruiting | 2025-07-18 | 2031-09-01 | ClinicalTrials.gov |
| NCT06604039 | A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascu… | — | Vascular Access Device | Recruiting | 2024-12-08 | 2034-12-07 | ClinicalTrials.gov |
| NCT06496256 | Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial | Na | Prostate Cancer | Recruiting | 2024-10-31 | 2027-12-31 | ClinicalTrials.gov |
| NCT06364865 | AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical P… | — | Gall Bladder Disease | Enrolling_By_Invitation | 2024-06-07 | 2025-08-30 | ClinicalTrials.gov |
| NCT06414187 | Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndro… | Na | Cardiogenic Shock | Not_Yet_Recruiting | 2024-06-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT05959018 | Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Preve… | Na | CLABSI - Central Line Associated Bloodstream Infection | Completed | 2024-01-19 | 2026-03-03 | ClinicalTrials.gov |
| NCT05936996 | Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes | — | Femoral Arteriotomy Closure | Completed | 2023-11-15 | 2025-10-30 | ClinicalTrials.gov |
| NCT05702515 | Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training… | — | Peripheral ICC | Completed | 2023-07-21 | 2024-06-26 | ClinicalTrials.gov |
| NCT05142566 | MANTA Ultrasound Closure Study | Na | Femoral Arteriotomy Closure | Terminated | 2022-08-09 | 2023-01-11 | ClinicalTrials.gov |
| NCT05148156 | Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate… | Na | Benign Prostatic Hyperplasia | Suspended | 2021-12-15 | 2028-03-01 | ClinicalTrials.gov |
| NCT04794348 | Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen… | Phase2 | Anticoagulant Reversal | Withdrawn | 2021-05-01 | 2022-03-01 | ClinicalTrials.gov |
| NCT04135547 | Venous Injection Compared To intraOsseous Injection During Resuscitation of Pat… | Na | Emergency Medical Service | Completed | 2020-07-06 | 2023-06-30 | ClinicalTrials.gov |
| NCT03988166 | Chronic Total Occlusion Percutaneous Coronary Intervention Study | Na | Chronic Total Occlusion | Completed | 2020-05-20 | 2021-02-22 | ClinicalTrials.gov |
| NCT05278507 | Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performan… | Na | Peripherally Inserted Central Catheter | Unknown | 2020-01-16 | 2023-06-30 | ClinicalTrials.gov |
| NCT03726203 | Laparoscopic Surgery: Comparison of Conventional Trocars to the Teleflex® MiniL… | Na | Gynecologic Surgeries | Completed | 2019-01-15 | 2021-04-27 | ClinicalTrials.gov |
| NCT03725293 | Midlines and Thrombophlebitis | Na | Catheter Infection | Completed | 2019-01-14 | 2020-11-26 | ClinicalTrials.gov |
| NCT03633942 | Safety and Efficacy of the LMA Supreme When Inserted With Patients in the Prone… | — | Airway Obstruction | Unknown | 2018-07-27 | 2020-07-27 | ClinicalTrials.gov |
| NCT03486002 | EFFEXTS OF THE CLEANSWEEP SUCTION CATHETER | Na | Endotracheal Tube Clearance | Terminated | 2018-07-17 | 2020-04-17 | ClinicalTrials.gov |
| NCT03272776 | Multicenter Study of the Protector Laryngeal Mask | — | Airway | Completed | 2017-08-01 | 2018-07-30 | ClinicalTrials.gov |
| NCT03004560 | Psychology of Minimally Invasive Surgical Scars | Na | Obesity | Terminated | 2017-01-01 | 2019-12-31 | ClinicalTrials.gov |
| NCT03019302 | Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study | Na | Vascular Access Complication | Unknown | 2016-12-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02662023 | Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus … | Phase4 | Postoperative Pain | Completed | 2016-02-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02685995 | VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC | Na | Renal Failure Chronic Requiring Hemodialysis | Completed | 2015-12-01 | 2020-07-01 | ClinicalTrials.gov |
| NCT02428413 | Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zo… | Na | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | Completed | 2015-04-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01807884 | Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechan… | Na | Ventilator Acquired Pneumonia | Completed | 2014-11-12 | 2016-03-04 | ClinicalTrials.gov |
| NCT01759277 | Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthr… | Phase4 | Postoperative Pain Following Knee Arthroplasty | Completed | 2012-12-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01578993 | Observational Study of Complications Related to Use of Peripherally Inserted Ce… | — | Adult Patients With Peripherally Inserted Central Catheters | Completed | 2012-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01386879 | Evaluation of Above the Cuff Suctioning During General Anesthesia | Phase4 | Secretion Removal Above ETT Cuff | Terminated | 2011-07-01 | 2012-10-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System | Other | Approved | Coronary Artery Disease | RECRUITING | NCT06779630 |
| Xience DES | Other | Approved | Coronary Disease | RECRUITING | NCT07258290 |
| Freesolve RMS | Other | Approved | Coronary Disease | RECRUITING | NCT07258290 |
| Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System | Other | Approved | Coronary Artery Disease | RECRUITING | NCT06779630 |
| Standard oxygen mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| ISO-Gard Mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| Standard oxygen mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| ISO-Gard Mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| Standard oxygen mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| ISO-Gard Mask | Other | Approved | Waste Anesthetic Gas (WAG) Emanating From Patients Post-operative Recovery | COMPLETED | NCT02428413 |
| Arrow PICC with Chloragard Technology | Other | Approved | Vascular Access Complication | UNKNOWN | NCT03019302 |
| Arrow PICC with Chloragard Technology | Other | Approved | Vascular Access Complication | UNKNOWN | NCT03019302 |
| Routine oral care | Other | Approved | Ventilator Acquired Pneumonia | COMPLETED | NCT01807884 |
| Optimized oral care | Other | Approved | Ventilator Acquired Pneumonia | COMPLETED | NCT01807884 |
| Routine oral care | Other | Approved | Ventilator Acquired Pneumonia | COMPLETED | NCT01807884 |
| Optimized oral care | Other | Approved | Ventilator Acquired Pneumonia | COMPLETED | NCT01807884 |
| LMA Supreme | Other | Preclinical | Airway Obstruction | UNKNOWN | NCT03633942 |
| LMA Supreme | Other | Preclinical | Airway Obstruction | UNKNOWN | NCT03633942 |
| Protector Laryngeal Mask airway | Other | Preclinical | Airway | COMPLETED | NCT03272776 |
| Protector Laryngeal Mask airway | Other | Preclinical | Airway | COMPLETED | NCT03272776 |
| Protector Laryngeal Mask airway | Other | Preclinical | Airway | COMPLETED | NCT03272776 |
| Protector Laryngeal Mask airway | Other | Preclinical | Airway | COMPLETED | NCT03272776 |
| Percutaneous Approach | Other | Approved | Obesity | TERMINATED | NCT03004560 |
| Standard Laparoscopic Approach | Other | Approved | Obesity | TERMINATED | NCT03004560 |
| Halyard | Other | Approved | Endotracheal Tube Clearance | TERMINATED | NCT03486002 |
| Cleansweep | Other | Approved | Endotracheal Tube Clearance | TERMINATED | NCT03486002 |
| Halyard | Other | Approved | Endotracheal Tube Clearance | TERMINATED | NCT03486002 |
| Cleansweep | Other | Approved | Endotracheal Tube Clearance | TERMINATED | NCT03486002 |
| Palindrome TDC | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT02685995 |
| VectorFlow TDC | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT02685995 |
| Basal | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| Bolus | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| Basal | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| Bolus | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| Basal | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| Bolus | Other | Phase PHASE4 | Postoperative Pain | COMPLETED | NCT02662023 |
| laparoscopic gynecologic surgery with the conventional single-use trocars. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| laparoscopic gynecologic surgery with the MiniLap System. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| laparoscopic gynecologic surgery with the conventional single-use trocars. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| laparoscopic gynecologic surgery with the MiniLap System. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| laparoscopic gynecologic surgery with the conventional single-use trocars. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| laparoscopic gynecologic surgery with the MiniLap System. | Procedure | Approved | Gynecologic Surgeries | COMPLETED | NCT03726203 |
| Teleflex Arrowg+ard Blue Advanced Midline Catheter | Other | Approved | Catheter Infection | COMPLETED | NCT03725293 |
| Angiodynamics BioFlo Midline Catheter | Other | Approved | Catheter Infection | COMPLETED | NCT03725293 |
| Teleflex Arrowg+ard Blue Advanced Midline Catheter | Other | Approved | Catheter Infection | COMPLETED | NCT03725293 |
| Angiodynamics BioFlo Midline Catheter | Other | Approved | Catheter Infection | COMPLETED | NCT03725293 |
| methylene blue | Other | Phase PHASE4 | Secretion Removal Above ETT Cuff | TERMINATED | NCT01386879 |
| methylene blue | Other | Phase PHASE4 | Secretion Removal Above ETT Cuff | TERMINATED | NCT01386879 |
| methylene blue | Other | Phase PHASE4 | Secretion Removal Above ETT Cuff | TERMINATED | NCT01386879 |
| methylene blue | Other | Phase PHASE4 | Secretion Removal Above ETT Cuff | TERMINATED | NCT01386879 |
| GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter | Other | Approved | Chronic Total Occlusion | COMPLETED | NCT03988166 |
| Chronic Total Occlusion Revascularization | Other | Approved | Chronic Total Occlusion | COMPLETED | NCT03988166 |
| GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter | Other | Approved | Chronic Total Occlusion | COMPLETED | NCT03988166 |
| Chronic Total Occlusion Revascularization | Other | Approved | Chronic Total Occlusion | COMPLETED | NCT03988166 |
| Sham Comparator PICC placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| Arrowga+rd Blue Advance Protection PICC Placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| Sham Comparator PICC placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| Arrowga+rd Blue Advance Protection PICC Placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| Sham Comparator PICC placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| Arrowga+rd Blue Advance Protection PICC Placement | Other | Approved | Peripherally Inserted Central Catheter | UNKNOWN | NCT05278507 |
| MANTA Vascular Closure Device | Device | Approved | Femoral Arteriotomy Closure | TERMINATED | NCT05142566 |
| MANTA Vascular Closure Device | Device | Approved | Femoral Arteriotomy Closure | TERMINATED | NCT05142566 |
| intra-osseous access vs. intra-venous access | Other | Approved | Emergency Medical Service | COMPLETED | NCT04135547 |
| intra-osseous access vs. intra-venous access | Other | Approved | Emergency Medical Service | COMPLETED | NCT04135547 |
| Intra-Aortic Balloon Pump | Other | Approved | Cardiogenic Shock | NOT_YET_RECRUITING | NCT06414187 |
| Intra-Aortic Balloon Pump | Other | Approved | Cardiogenic Shock | NOT_YET_RECRUITING | NCT06414187 |
| Intra-Aortic Balloon Pump | Other | Approved | Cardiogenic Shock | NOT_YET_RECRUITING | NCT06414187 |
| Intra-Aortic Balloon Pump | Other | Approved | Cardiogenic Shock | NOT_YET_RECRUITING | NCT06414187 |
| Arrowg+ard Blue Plus® Three-Lumen Central Venous Catheter | Other | Approved | CLABSI - Central Line Associated Bloodstream Infection | RECRUITING | NCT05959018 |
| Arrow Three-Lumen Central Venous Catheter | Other | Approved | CLABSI - Central Line Associated Bloodstream Infection | RECRUITING | NCT05959018 |
| Digital ECG Data Collection | Other | Preclinical | Peripheral ICC | COMPLETED | NCT05702515 |
| Digital ECG Data Collection | Other | Preclinical | Peripheral ICC | COMPLETED | NCT05702515 |
| Transrectal Ultrasound | Other | Approved | Prostate Cancer | RECRUITING | NCT06496256 |
| Barrigel | Other | Approved | Prostate Cancer | RECRUITING | NCT06496256 |
| Transrectal Ultrasound | Other | Approved | Prostate Cancer | RECRUITING | NCT06496256 |
| Barrigel | Other | Approved | Prostate Cancer | RECRUITING | NCT06496256 |
| laparoscopic procedure | Procedure | Preclinical | Gall Bladder Disease | ENROLLING_BY_INVITATION | NCT06364865 |
| laparoscopic procedure | Procedure | Preclinical | Gall Bladder Disease | ENROLLING_BY_INVITATION | NCT06364865 |
| Central venous catheter | Other | Preclinical | Vascular Access Device | RECRUITING | NCT06604039 |
| Central venous catheter | Other | Preclinical | Vascular Access Device | RECRUITING | NCT06604039 |
| MANTA Vascular Closure Device | Device | Preclinical | Femoral Arteriotomy Closure | COMPLETED | NCT05936996 |
| MANTA Vascular Closure Device | Device | Preclinical | Femoral Arteriotomy Closure | COMPLETED | NCT05936996 |
| Xience DES | Other | Approved | Coronary Disease | NOT_YET_RECRUITING | NCT07258290 |
| Freesolve RMS | Other | Approved | Coronary Disease | NOT_YET_RECRUITING | NCT07258290 |
| Urolift | Other | Approved | Benign Prostatic Hyperplasia | SUSPENDED | NCT05148156 |
| Urolift | Other | Approved | Benign Prostatic Hyperplasia | SUSPENDED | NCT05148156 |
| Barrigel gel spacer | Other | Phase PHASE1 | Cervix Cancer | RECRUITING | NCT07292818 |
| Barrigel gel spacer | Other | Phase PHASE1 | Cervix Cancer | RECRUITING | NCT07292818 |
| Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System | Other | Approved | Coronary Artery Disease | RECRUITING | NCT06779630 |
| Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System | Other | Approved | Coronary Artery Disease | RECRUITING | NCT06779630 |
| Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System | Other | Approved | Coronary Artery Disease | RECRUITING | NCT06779630 |
| Arrowg+ard Blue Plus® Three-Lumen Central Venous Catheter | Other | Approved | CLABSI - Central Line Associated Bloodstream Infection | COMPLETED | NCT05959018 |
| Arrow Three-Lumen Central Venous Catheter | Other | Approved | CLABSI - Central Line Associated Bloodstream Infection | COMPLETED | NCT05959018 |